Loading organizations...
Loading organizations...
salauno is dedicated to providing ophthalmological services to improve visual health for all Mexicans. They offer consultations and treatments for various eye conditions, including cataracts, glaucoma, and retinal issues.
Salauno is a technology-driven ophthalmology company based in Mexico that provides affordable, high-quality eye care services, including surgeries, diagnostics, and treatments for various visual impairments. It serves a broad demographic, aiming to make vision care accessible to all income levels, addressing a critical public health issue where millions suffer from preventable or reversible blindness. Salauno’s model leverages technology such as tele-diagnostics and machine learning to increase efficiency and reach, operating a network of over 20 clinics and serving hundreds of thousands of patients since its founding. The company’s growth is marked by expanding its service lines and geographic footprint while maintaining affordable pricing and quality care[1][2][3].
Founded in 2011, Salauno was created to tackle the widespread problem of visual impairment and blindness in Mexico, where millions suffer from untreated eye conditions like cataracts, glaucoma, and diabetic retinopathy. The founders, motivated by the social impact of vision loss on individuals’ quality of life and economic productivity, developed an innovative model combining clinical excellence with operational efficiency. Early traction came from establishing a single surgical center in Mexico City, which expanded into a network of diagnostic and surgical centers. Pivotal moments include the introduction of “Intelligent Surgery,” a service allowing private ophthalmologists to rent surgical facilities during off-peak times, improving utilization and broadening the company’s professional network[1][2].
Salauno rides the global trend of leveraging technology to democratize healthcare access, particularly in emerging markets where specialized care is scarce. The timing is critical given Mexico’s high burden of preventable blindness and the increasing availability of digital health tools. Market forces such as rising chronic diseases (e.g., diabetes) that affect eye health, government interest in public health partnerships, and patient demand for affordable quality care favor Salauno’s growth. By integrating AI and telemedicine, Salauno not only improves patient outcomes but also sets a scalable model for tech-enabled specialty care in Latin America, influencing broader healthcare delivery innovation in the region[1][2][7].
Salauno is poised to continue expanding its network and technological capabilities, potentially increasing its market share in Mexico and possibly other Latin American countries. Trends such as AI in diagnostics, telehealth adoption, and value-based care models will shape its evolution. The company’s influence may grow as a benchmark for combining social impact with sustainable business in healthcare, driving innovation in affordable specialty services. Future developments could include deeper integration of predictive analytics, expanded remote care, and partnerships with public health systems to further reduce preventable blindness at scale[1][7]. This trajectory aligns with its mission to ensure that quality vision care is not a luxury but a right accessible to all.
salauno has raised $15.0M in total across 1 funding round.
salauno's investors include Canary Ventures, Endeavor Catalyst, FJ Labs, Graph Ventures.
salauno has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series B in June 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2019 | $15.0M Series B | Canary Ventures, Endeavor Catalyst, FJ Labs, Graph Ventures |
